The following is a summary of “Trough levels of dalbavancin during long-term treatment of prosthetic joint infections,” ...

Donanemab is only for use in the early stages of Alzheimer’s disease. And for now at least, it comes with a hefty price tag.

The aim of this study was to investigate the factors influencing voriconazole (VRC) plasma trough concentrations (Ctrough ... Inflammation, as indicated by C-reactive protein (CRP) levels, was ...

Despite two decades of clinical experience with Everolimus in transplant medicine, cancer patients continue to face ...

Patients with stroke and a mild or moderate level of neurologic impairment can be monitored less intensively after thrombolysis with no safety issues, a new study suggests.

1, N/OFQ–NOP is involved in a wide range of responses and thus has wide potential for drug development ... elevated circulating NOP antagonist levels, which might be problematic in patients ...

at the cellular level?” Clinical trial participation, she went on, was vital. Samit Hirawat, chief medical officer for global drug development at Bristol Myers Squibb called it a “scientific ...

By increasing the production of dopamine in the brain, the drug can also cause feelings of euphoria and improved mood. What does Adderall do to a normal person? In people whose levels of dopamine ...

While people with diabetes can keep better tabs on their blood sugar levels when awake ... people with diabetes may use continuous glucose monitoring (CGM) to manage and prevent low blood sugar.

Merck booked just under $600 million last year in alliance revenues from the pair, but its attention is now moving to new therapies including sotatercept, a TGF-beta-targeting PAH drug Merck ...

This property, when coupled with a redox reporter and electrochemical detection, enables reagent-free biosensing with a subminute temporal resolution for in vivo therapeutic drug monitoring.